Inquiry Basket
Loading ......
Filter By Product Search for
PROC
PROC Full Name
protein C (inactivator of coagulation factors Va and VIIIa)
PROC Introduction
Protein C (PROC) is a vitamin K–dependent plasma glycoprotein synthesized primarily in the liver and plays a pivotal role in maintaining the balance between coagulation and anticoagulation. As the precursor of activated protein C (APC), it functions as a natural inhibitor of coagulation by targeting factors Va and VIIIa, preventing excessive thrombin generation. For many readers focused on thrombosis risk, vascular health, or systemic inflammatory disorders, PROC is increasingly recognized as more than a classical anticoagulant factor. Recent biological insights suggest that disturbances in the protein C system are closely linked to metabolic conditions such as obesity, where reduced sensitivity to activated protein C contributes to a chronic prothrombotic and inflammatory state. This connection helps explain why patients with metabolic dysfunction often face a higher risk of venous thromboembolism, highlighting PROC as a mechanistic bridge between metabolism, inflammation, and coagulation.
Beyond its anticoagulant activity, activated protein C exerts broad cytoprotective and anti-inflammatory functions that are highly relevant to disease progression and therapeutic exploration. Through interactions with endothelial receptors, APC supports vascular barrier integrity, modulates immune cell activation, and dampens excessive inflammatory signaling. These multifunctional effects clarify why abnormalities in PROC expression or activity can lead to complex clinical manifestations rather than isolated clotting disorders. Genetic variability in the PROC gene further amplifies this complexity: different mutations can result in markedly different phenotypes, ranging from severe congenital protein C deficiency with early-onset thrombosis to milder, late-presenting thrombotic tendencies. Understanding this genetic and functional diversity is critical for accurate diagnosis, risk assessment, and the development of precision-based clinical strategies.
From a disease relevance and biomarker standpoint, PROC is gaining increasing attention across a wide spectrum of clinical fields. Altered protein C levels have been observed in inflammatory diseases, malignancy-associated thrombosis, and systemic disorders characterized by endothelial dysfunction, suggesting that PROC reflects both coagulation status and underlying inflammatory burden. This dual relevance makes it particularly valuable for clinicians and researchers seeking biomarkers that go beyond traditional coagulation factors. As interest grows in predicting thrombotic risk, monitoring disease severity, and identifying new therapeutic targets, PROC stands out as a biologically robust and clinically meaningful molecule with expanding implications across hematology, oncology, and inflammatory disease research.
Alternate Names for PROC
PROC; protein C (inactivator of coagulation factors Va and VIIIa); PC; APC; PROC1; THPH3; THPH4; vitamin K-dependent protein C; prepro-protein C; autoprothrombin IIA; anticoagulant protein C; blood coagulation factor XIV;
Loading ......
